BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD Inc., provided a commercialization update on its recently acquired operating subsidiary, VerdaGenix LLC d/b/a Ancient Extracts USA, highlighting strong early operating results and continued progress in the company's transition toward a revenue-generating wellness platform.
Management completed its preliminary review of Ancient Extracts' operating results for May 2026. Preliminary April 2026 revenue was approximately $12,670, while preliminary May 2026 revenue increased to approximately $22,344, representing approximately 76% month-over-month growth. The company noted that operations commenced under UNLOCKD ownership during the middle of May following the closing of the acquisition, so the reported May revenue reflects only a partial month of operations under company ownership.
In addition, on June 2, 2026, Ancient Extracts received a purchase order representing approximately $58,823 in retail product value, with an order total of approximately $29,411 under wholesale pricing terms. All financial figures disclosed are preliminary, unaudited, and subject to further review.
John P. Gorst, Chief Executive Officer of UNLOCKD, stated: "We remain in the early stages of integrating Ancient Extracts into the UNLOCKD organization, but we are encouraged by the commercial momentum we are seeing. The combination of accelerating revenue, customer demand, and expanding distribution opportunities reinforces our belief that Ancient Extracts possesses many of the qualities that originally attracted us to this acquisition. Our focus remains on disciplined execution, strengthening operations, expanding distribution, and creating long-term shareholder value through sustainable growth."
Ancient Extracts USA offers a growing portfolio of functional mushroom products, ceremonial teas, cacao blends, matcha products, shilajit, and wellness-focused consumer goods marketed under the brand philosophy of "Ancient Remedies for Modern Life." The company believes the brand is well positioned to benefit from growing consumer interest in functional mushrooms, adaptogens, botanical wellness products, and evidence-informed approaches to health and human performance.
Management believes Ancient Extracts provides UNLOCKD with a capital-efficient operating foundation from which to pursue additional commercialization opportunities, strategic partnerships, product innovation, and long-term expansion initiatives.
Dr. Jordan P. Balencic, Chairman and Chief Science Officer of UNLOCKD, commented: "When we evaluated Ancient Extracts, we believed the business possessed a number of attractive characteristics, including a differentiated product portfolio, a loyal customer base, a capital-efficient operating model, and multiple pathways for future growth. While it remains early in the integration process, the initial operating results and commercial traction we are seeing continue to reinforce our conviction in the opportunity."
Dr. Balencic continued: "Our objective is straightforward: grow revenue, expand distribution, strengthen our portfolio of wellness assets, and execute with discipline. We believe Ancient Extracts provides a strong operating nucleus capable of supporting broader growth initiatives across wellness, functional nutrition, cognitive health, and human optimization. We remain focused on creating durable long-term value through operational execution rather than promotional activity."
Separately, the company announced that its UNLOCKD Technologies division has begun preliminary planning activities related to future consumer health technology opportunities. Management has initiated early-stage evaluation of certain point-of-care testing concepts and has engaged in preliminary discussions with developers, suppliers, and potential strategic partners. These initiatives remain in the conceptual and planning stages, and the company expects any future technology development efforts to follow a disciplined, milestone-driven approach, anticipating dedicated financing rather than using capital intended for current operating activities.
The implications of this announcement highlight UNLOCKD's successful integration of Ancient Extracts, demonstrating rapid revenue growth and strong customer demand in the functional wellness market. This positions the company for potential expansion in the growing adaptogen and functional mushroom sector, which could impact the broader wellness industry by validating capital-efficient acquisition strategies. For investors, the preliminary results and purchase orders signal early traction in UNLOCKD's transition to a revenue-generating platform, though the company cautions that these figures are preliminary and subject to adjustment.
